Halodine Nasal Antiseptic in Patients With COVID-19

Clinical trial NCT04517188 · UNKNOWN

Trial details

NCT number: NCT04517188
Sponsor: Halodine LLC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-04-01
Primary completion: 2021-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.